More
    Guided Solutions - Connecting Talent With Innovation/div>

    SynCardia parent prices $17M IPO to support next-gen artificial heart

    Picard Medical, the company behind the SynCardia Total Artificial Heart (TAH), announced the pricing of a $17 million initial public offering (IPO). The Tucson, Arizona–based...

    Vaxxas raises $58.4M for needle-free vaccine delivery tech

    Vaxxas announced raised $58.4 million (A$90 million) in a new financing round supporting its vaccine delivery technology. The Brisbane, Australia-based company picked up about $32...

    Avasa raises $2.8m pre-Series A for micro-artery coupling device

    Avasa completed the first close of its pre-Series A fundraising round worth about $2.8 million (NZD$4.75 million). Movac, one of New Zealand’s largest and longest-standing...

    Twin Health secures $53m to accelerate AI Digital Twin for metabolic health

    Twin Health, a company focused on using AI digital twin technology for metabolic health, has announced a $53M investment led by Maj Invest of...

    ProVerum secures $80m Series B to advance nitinol stent for BPH

    ProVerum Limited, the developer of the ProVee System for BPH, a minimally invasive solution for treating benign prostatic hyperplasia (BPH), announced the closing of...

    Terumo to acquire organ preservation device maker OrganOx for $1.5B

    Terumo entered into a definitive agreement to acquire OrganOx and its organ preservation technology. Tokyo-based Terumo agreed to acquire all outstanding OrganOx shares for approximately...

    Restor3d picks up $104m as Partners Group acquires minority stake

    Restor3d announced today that it entered into a strategic investment partnership with global private market firm Partners Group. The agreement sees Partners Group acquire a...

    Method AI raises $20m for image-guided surgery platform

    Method AI announced it raised $20 million in Series A funding to support its novel surgical ultrasound platform. The Boston-based company, co-founded by former Corindus...

    Iantrek raises $42m to fuel US glaucoma treatment launch

    Eyecare specialist Iantrek has raised $42m to support the US launch of its allogeneic graft for treating glaucoma. Through its bio-interventional ophthalmic surgery (BIOS) platform,...

    Latest articles